跳至主要内容
临床试验/NL-OMON45645
NL-OMON45645已完成不适用

TARC-002 EVALUATION OF THYMUS AND ACTIVATION REGULATED CHEMOKINE (TARC) IN PATIENTS WITH LYMPHADENOPATHY , FEVER OR NON-HODGKIN LYMPHOMA - TARC IN PATIENTS WITH LYMPHADENOPATH, FEVER OR NON-HODGKIN LYMPHOMA<br>

niversitair Medisch Centrum Groningen0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Age * 18 years;
  • - Ability to give written informed consent;
  • And one of the following:
  • (1) Lymph node enlargement of unknown cause for whicha diagnostic fine needle aspiration will be performedor
  • (2) Presenting with fever at the emergency department or
  • (3) Presenting with newly diagnosed or relapsed nodular lymphocyte predominant or non-Hodgkin lymphoma.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study (applicable to all subgroups):
  • - Ineligibility to give written informed consent;
  • - Patients with active atopic disease or hepatic failure;
  • - Patients already diagnosed with Hodgkin lymphoma

研究者

相似试验